litlas
ログインアカウント作成

Christopher R. Flowers

1990–2025 年に発表

202
論文数
32,137
被引用数
84
h 指数
183
i10 指数

被引用数

Christopher R. Flowers の年別被引用数1989 年: 被引用 1 件1996 年: 被引用 1 件1998 年: 被引用 1 件2000 年: 被引用 2 件2001 年: 被引用 1 件2002 年: 被引用 3 件2003 年: 被引用 7 件2004 年: 被引用 9 件2005 年: 被引用 36 件2006 年: 被引用 22 件2007 年: 被引用 21 件2008 年: 被引用 29 件2009 年: 被引用 44 件2010 年: 被引用 34 件2011 年: 被引用 54 件2012 年: 被引用 80 件2013 年: 被引用 106 件2014 年: 被引用 180 件2015 年: 被引用 216 件2016 年: 被引用 199 件2017 年: 被引用 224 件2018 年: 被引用 260 件2019 年: 被引用 1,095 件2020 年: 被引用 1,193 件2021 年: 被引用 1,247 件2022 年: 被引用 1,057 件2023 年: 被引用 892 件2024 年: 被引用 1,598 件2025 年: 被引用 709 件2026 年: 被引用 25 件1990〜1995 年は被引用が無いため表示していません1997 年は被引用が無いため表示していません1999 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 3,881 件、この内訳の 28%中国: 引用元論文 1,235 件、この内訳の 8.9%イギリス: 引用元論文 801 件、この内訳の 5.8%ドイツ: 引用元論文 754 件、この内訳の 5.4%イタリア: 引用元論文 753 件、この内訳の 5.4%カナダ: 引用元論文 657 件、この内訳の 4.7%フランス: 引用元論文 656 件、この内訳の 4.7%スペイン: 引用元論文 517 件、この内訳の 3.7%オランダ: 引用元論文 383 件、この内訳の 2.8%スイス: 引用元論文 364 件、この内訳の 2.6%オーストラリア: 引用元論文 343 件、この内訳の 2.5%日本: 引用元論文 263 件、この内訳の 1.9%
0%28%その他 23.6%

機関

分野

  • Medicine78.1%
  • Biochemistry, Genetics and Molecular Biology13.2%
  • Immunology and Microbiology4%
  • Computer Science1.5%
  • Health Professions0.8%
  • Engineering0.4%
  • その他2%

トピック

  • Lymphoma Diagnosis and Treatment9.3%
  • CAR-T cell therapy research6.4%
  • Chronic Lymphocytic Leukemia Research3.9%
  • Venous Thromboembolism Diagnosis and Management3.1%
  • Global Cancer Incidence and Screening3.1%
  • Colorectal Cancer Screening and Detection2.9%
  • その他71.3%

共著者

全論文

検索で開く
  1. Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

    著者: David Marín, Ye Li, Rafet Başar, Hind Rafei, May Daher, Jinzhuang Dou, Vakul Mohanty, Merve Dede, Yago Nieto, Nadima Uprety, Sunil Acharya, Enli Liu, Jeffrey M. Wilson, Pinaki P. Banerjee, Homer A. Macapinlac, Christina Ganesh, Peter F. Thall, Roland L. Bassett, Mariam Ammari, Sheetal Rao, Kai Cao, Mayra Shanley, Mecit Kaplan, Chitra Hosing, Partow Kebriaei, Loretta J. Nastoupil, Christopher R. Flowers, Sadie Mae Moseley, Paul Lin, Sonny Ang, Uday Popat, Muzaffar H. Qazilbash, Richard E. Champlin, Ken Chen, Elizabeth J. Shpall, Katayoun Rezvani - Nature Medicine 2024 被引用: 457

  2. Colorectal cancer screening for average‐risk adults: 2018 guideline update from the American Cancer Society

    著者: Andrew M. D. Wolf, Elizabeth T. H. Fontham, Timothy R. Church, Christopher R. Flowers, Carmen E. Guerra, Samuel J. LaMonte, Ruth Etzioni, Matthew T. McKenna, Kevin C. Oeffinger, Ya‐Chen Tina Shih, Louise C. Walter, Kimberly Andrews, Otis W. Brawley, Durado Brooks, Stacey A. Fedewa, Deana Manassaram‐Baptiste, Rebecca L. Siegel, Richard C. Wender, Robert A. Smith - CA A Cancer Journal for Clinicians 2018 被引用: 2,017

  3. Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma

    著者: Hervé Tilly, Franck Morschhauser, Laurie H. Sehn, Jonathan W. Friedberg, Marek Trněný, Jeff P. Sharman, Charles Herbaux, John M. Burke, Matthew Matasar, Shinya Rai, Koji Izutsu, Neha Mehta-Shah, Lucie Oberic, Adrien Chauchet, Wojciech Jurczak, Yuqin Song, Richard Greil, Larysa Mykhalska, Juan M. Bergua-Burgués, Matthew C. Cheung, Antonio Pinto, Ho-Jin Shin, Greg Hapgood, Eduardo Munhoz, Pau Abrisqueta, Jyh-Pyng Gau, Jamie Hirata, Yanwen Jiang, Mark Yan, Calvin Lee, Christopher R. Flowers, Gilles Salles - New England Journal of Medicine 2021 被引用: 843

  4. Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society

    著者: Elizabeth T. H. Fontham, Andrew M. D. Wolf, Timothy R. Church, Ruth Etzioni, Christopher R. Flowers, Abbe Herzig, Carmen E. Guerra, Kevin C. Oeffinger, Ya‐Chen Tina Shih, Louise C. Walter, Jane J. Kim, Kimberly Andrews, Carol DeSantis, Stacey A. Fedewa, Deana Manassaram‐Baptiste, Debbie Saslow, Richard C. Wender, Robert A. Smith - CA A Cancer Journal for Clinicians 2020 被引用: 970

  5. A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy

    著者: Christoph K. Stein‐Thoeringer, Neeraj Saini, Eli Zamir, Viktoria Blumenberg, Maria‐Luisa Schubert, Uria Mor, Matthias Fante, Sabine Schmidt, Eiko Hayase, Tomo Hayase, Roman Rohrbach, Chia‐Chi Chang, Lauren McDaniel, Ivonne I. Flores, Rogier Gaiser, Matthias Edinger, Daniel Wolff, Martin Heidenreich, Paolo Strati, Ranjit Nair, Dai Chihara, Luis Fayad, Sairah Ahmed, Swaminathan P. Iyer, Raphaël Steiner, Preetesh Jain, Loretta J. Nastoupil, Jason R. Westin, Reetakshi Arora, Michael Wang, Joel G. Turner, Meghan Menges, Melanie J. Hidalgo-Vargas, Kayla Reid, Peter Dreger, Anita Schmitt, Carsten Müller‐Tidow, Frederick L. Locke, Marco L. Davila, Richard E. Champlin, Christopher R. Flowers, Elizabeth J. Shpall, Hendrik Poeck, Sattva S. Neelapu, Michael Schmitt, Marion Subklewe, Michael D. Jain, Robert R. Jenq, Eran Elinav - Nature Medicine 2023 被引用: 226

  6. Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    著者: Laurie H. Sehn, Alex F. Herrera, Christopher R. Flowers, Manali Kamdar, Andrew McMillan, Mark Hertzberg, Sarit Assouline, Tae Min Kim, Won Seog Kim, Muhıt Özcan, Jamie Hirata, Elicia Penuel, Joseph N. Paulson, Ji Cheng, Grace Ku, Matthew J. Matasar - Journal of Clinical Oncology 2019 被引用: 772

  7. Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma

    著者: Anupama Reddy, Jenny Zhang, Nicholas S. Davis, Andrea B. Moffitt, Cassandra Love, Alexander Waldrop, Sirpa Leppä, Annika Pasanen, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg, Peter Nørgaard, Mette Ølgod Pedersen, Anne Ortved Gang, Estrid Høgdall, Tayla B. Heavican, Waseem Lone, Javeed Iqbal, Qiu Qin, Guojie Li, So Young Kim, Jane Healy, Kristy L. Richards, Yuri Fedoriw, Leon Bernal‐Mizrachi, Jean L. Koff, Ashley D. Staton, Christopher R. Flowers, Ora Paltiel, Neta Goldschmidt, Maria Calaminici, Andrew Clear, John G. Gribben, Evelyn Nguyen, Magdalena Czader, Sarah L. Ondrejka, Angela M. B. Collie, Eric D. Hsi, Eric Tse, Rex Au-Yeung, Yok‐Lam Kwong, Gopesh Srivastava, William W.L. Choi, Andrew M. Evens, Monika Pilichowska, Manju Sengar, Nishitha Reddy, Shaoying Li, Amy Chadburn, Leo I. Gordon, Elaine S. Jaffe, Shawn Levy, Rachel E. Rempel, Tiffany J. Tzeng, Lanie E. Happ, Tushar Dave, Deepthi Rajagopalan, Jyotishka Datta, David B. Dunson, Sandeep S. Davé - Cell 2017 被引用: 1,146

  8. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update

    著者: Nigel S. Key, Alok A. Khorana, Nicole M. Kuderer, Kari Bohlke, Agnes Lee, Juan I. Arcelus, Sandra L. Wong, Edward P. Balaban, Christopher R. Flowers, Charles W. Francis, Leigh E. Gates, Ajay K. Kakkar, Mark N. Levine, Howard A. Liebman, Margaret A. Tempero, Gary H. Lyman, Anna Falanga - Journal of Clinical Oncology 2019 被引用: 1,475

  9. Breast Cancer Screening for Women at Average Risk

    著者: Kevin C. Oeffinger, Elizabeth T. H. Fontham, Ruth Etzioni, Abbe Herzig, James Michaelson, Ya‐Chen Tina Shih, Louise C. Walter, Timothy R. Church, Christopher R. Flowers, Samuel J. LaMonte, Andrew M. D. Wolf, Carol DeSantis, Joannie Lortet‐Tieulent, Kimberly Andrews, Deana Manassaram‐Baptiste, Debbie Saslow, Robert A. Smith, Otis W. Brawley, Richard C. Wender - JAMA 2015 被引用: 1,648

  10. 2016 US lymphoid malignancy statistics by World Health Organization subtypes

    著者: Lauren R. Teras, Carol DeSantis, James R. Cerhan, Lindsay M. Morton, Ahmedin Jemal, Christopher R. Flowers - CA A Cancer Journal for Clinicians 2016 被引用: 1,139

  11. Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Guideline Update

    著者: Nigel S. Key, Alok A. Khorana, Nicole M. Kuderer, Kari Bohlke, Agnes Lee, Juan I. Arcelus, Sandra L. Wong, Edward P. Balaban, Christopher R. Flowers, Leigh E. Gates, Ajay K. Kakkar, Margaret A. Tempero, Shilpi Gupta, Gary H. Lyman, Anna Falanga - Journal of Clinical Oncology 2023 被引用: 317

  12. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update

    著者: Randy Taplitz, Erin B. Kennedy, Eric J. Bow, Jennie R. Crews, Charise Gleason, Douglas K. Hawley, Amelia Langston, Loretta J. Nastoupil, Michelle Rajotte, Kenneth V. I. Rolston, Lynne Strasfeld, Christopher R. Flowers - Journal of Clinical Oncology 2018 被引用: 580

  13. International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI

    著者: Amy S. Ruppert, Jesse G. Dixon, Gilles Salles, Anna Wall, David Cunningham, Viola Poeschel, Corinne Haïoun, Hervé Tilly, Hervé Ghesquières, Marita Ziepert, Jocelyne Flament, Christopher R. Flowers, Qian Shi, Norbert Schmitz - Blood 2020 被引用: 378

  14. Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study

    著者: Carla Casulo, Michelle Byrtek, Keith Dawson, Xiaolei Zhou, Charles M. Farber, Christopher R. Flowers, John D. Hainsworth, Matthew J. Maurer, James R. Cerhan, Brian K. Link, Andrew D. Zelenetz, Jonathan W. Friedberg - Journal of Clinical Oncology 2015 被引用: 844

  15. Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma

    著者: Paolo Strati, Sairah Ahmed, Fateeha Furqan, Luis Fayad, Hun Ju Lee, Swaminathan P. Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria Alma Rodriguez, Felipe Samaniego, Raphaël Steiner, Michael Wang, Chelsea C. Pinnix, Sandra B. Horowitz, Lei Feng, Ryan Sun, Catherine M. Claussen, Misha Hawkins, Nicole Johnson, Prachee Singh, Haleigh Mistry, Swapna Johncy, Sherry Adkins, Partow Kebriaei, Elizabeth J. Shpall, Michael R. Green, Christopher R. Flowers, Jason R. Westin, Sattva S. Neelapu - Blood 2021 被引用: 214

  16. PI3Kδ/γ inhibition promotes human CART cell epigenetic and metabolic reprogramming to enhance antitumor cytotoxicity

    著者: Christopher Ronald Funk, Shuhua Wang, Kevin Z. Chen, Alexandra Waller, Aditi Sharma, Claudia L. Edgar, Vikas A. Gupta, Shanmuganathan Chandrakasan, Jaquelyn T. Zoine, Andrew Fedanov, Sunil S. Raikar, Jean L. Koff, Christopher R. Flowers, Sílvia Coma, Jonathan A. Pachter, Sruthi Ravindranathan, H. Trent Spencer, Mala Shanmugam, Edmund K. Waller - Blood 2022 被引用: 132

  17. Validation of POD24 as a robust early clinical end point of poor survival in FL from 5225 patients on 13 clinical trials

    著者: Carla Casulo, Jesse G. Dixon, Jennifer Le‐Rademacher, Eva Hoster, Howard S. Höchster, Wolfgang Hiddemann, Robert Marcus, Eva Kimby, Michael Herold, Catherine Sebban, Emmanuel Gyan, Kenneth A. Foon, Tina Nielsen, Umberto Vitolo, Gilles Salles, Qian Shi, Christopher R. Flowers - Blood 2022 被引用: 163

  18. Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphoma

    著者: Chelsea C. Pinnix, Jillian R. Gunther, Bouthaina S. Dabaja, Paolo Strati, Penny Fang, Misha Hawkins, Sherry Adkins, Jason R. Westin, Sairah Ahmed, Luis Fayad, Hun Ju Lee, Ranjit Nair, Raphaël Steiner, Swaminathan P. Iyer, Maria Alma Rodriguez, Michael Wang, Christopher R. Flowers, Sattva S. Neelapu, Loretta J. Nastoupil - Blood Advances 2020 被引用: 224

  19. Polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory DLBCL: survival update and new extension cohort data

    著者: Laurie H. Sehn, Mark Hertzberg, Stephen Opat, Alex F. Herrera, Sarit Assouline, Christopher R. Flowers, Tae Min Kim, Andrew McMillan, Muhıt Özcan, Violaine Safar, Gilles Salles, Grace Ku, Jamie Hirata, Yi Meng Chang, Lisa Musick, Matthew J. Matasar - Blood Advances 2021 被引用: 177

  20. CRP and ferritin in addition to the EASIX score predict CAR-T–related toxicity

    著者: Uri Greenbaum, Paolo Strati, Rima M. Saliba, Janet Rodríguez‐Torres, Gabriela Rondón, Yago Nieto, Chitra Hosing, Samer A. Srour, Jason R. Westin, Luis Fayad, Hun Ju Lee, Swaminathan P. Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria Alma Rodriguez, Felipe Samaniego, Raphaël Steiner, Michael Wang, Chelsea C. Pinnix, Christopher R. Flowers, Sudhakar Tummala, Jeremy Ramdial, Fevzi Yalniz, Misha Hawkins, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Sattva S. Neelapu, Partow Kebriaei, Sairah Ahmed - Blood Advances 2021 被引用: 146

  21. TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma

    著者: Changying Jiang, Dapeng Hao, Preetesh Jain, Yijing Li, Qingsong Cai, Yixin Yao, Lei Nie, Yang Liu, Jingling Jin, Wei Wang, Heng‐Huan Lee, Yuxuan Che, Enyu Dai, Guangchun Han, Ruiping Wang, Kunal Rai, P. Andrew Futreal, Christopher R. Flowers, Linghua Wang, Michael Wang - Molecular Cancer 2022 被引用: 75

  22. The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma

    著者: Dai Chihara, Graça M. Dores, Christopher R. Flowers, Lindsay M. Morton - Blood 2021 被引用: 50

  23. Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

    著者: Guangchun Han, Qing Deng, Mario L. Marques‐Piubelli, Enyu Dai, Minghao Dang, Man Chun John, Xubin Li, Haopeng Yang, Jared Henderson, Olga Kudryashova, Mark Meerson, Sergey Isaev, Nikita Kotlov, Krystle Nomie, Alexander Bagaev, Edwin R. Parra, Luisa M. Solis Soto, Simrit Parmar, Fredrick B. Hagemeister, Sairah Ahmed, Swaminathan P. Iyer, Felipe Samaniego, Raphaël Steiner, Luis Fayad, Hun Ju Lee, Nathan Fowler, Christopher R. Flowers, Paolo Strati, Jason R. Westin, Sattva S. Neelapu, Loretta J. Nastoupil, Francisco Vega, Linghua Wang, Michael R. Green - Blood Cancer Discovery 2022 被引用: 101

  24. PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma

    著者: Ajay K. Gopal, Brad S. Kahl, Sven de Vos, Nina D. Wagner‐Johnston, Stephen J. Schuster, Wojciech Jurczak, Ian W. Flinn, Christopher R. Flowers, Peter Martin, Andreas Viardot, Kristie A. Blum, André Goy, Andrew Davies, Pier Luigi Zinzani, Martin Dreyling, Dave Johnson, Langdon L. Miller, Leanne Holes, Daniel Li, Roger Dansey, Wayne R. Godfrey, Gilles Salles - New England Journal of Medicine 2014 被引用: 1,062